In a 12-week, double-blind, placebo-controlled study involving 64 individuals with type 2 diabetes (T2D), Sugar Shiftdemonstrated significant efficacy in stabilizing fasting glucose, lowering serum LPS levels, and improving insulin sensitivity as measured by the HOMA-IR index [10]. Here, INS is linked to type 2 diabetes mellitus.